Document 1054
 DOCN  M9621054
 TI    HIV transmission and Kaposi's sarcoma among European women.
 DT    9602
 AU    Serraino D; Franceschi S; Dal Maso L; La Vecchia C; Department of
       Epidemiology, Aviano Cancer Centre, Italy.
 SO    AIDS. 1995 Aug;9(8):971-3. Unique Identifier : AIDSLINE MED/96014975
 AB    OBJECTIVE: To assess the association between the presence of Kaposi's
       sarcoma (KS) as an AIDS-defining illness and HIV transmission categories
       among European women with AIDS. DESIGN: Comparison of the prevalence of
       KS as an AIDS-defining illness in different HIV transmission categories.
       METHODS: Odds ratios (OR) and 95% confidence intervals (CI) for KS were
       computed by means of unconditional multiple logistic regression
       equations. RESULTS: KS was reported in 344 (2.2%) out of 15,809 women
       diagnosed with AIDS. Women who reported HIV infection via heterosexual
       intercourse had a > twofold increase of KS risk than intravenous drug
       users (OR, 2.4; 95% CI, 1.9-3.0). Particularly elevated OR were observed
       among women originating from African or Caribbean countries (OR, 4.9;
       95% CI, 3.7--6.5), and in partners of bisexual men (OR, 4.8; 95% CI,
       2.8--8.2). Such risk patterns for KS were consistent in different
       countries, age groups and year of AIDS diagnosis. CONCLUSIONS: These
       results are in agreement with similar analyses from the United States,
       and support the existence of some putative KS agent(s) which can be
       acquired via sexual intercourse with bisexual men, or earlier in life in
       countries where non-AIDS-associated KS is frequent.
 DE    Acquired Immunodeficiency Syndrome/COMPLICATIONS/EPIDEMIOLOGY  Adult
       Europe  Female  Human  HIV
       Infections/COMPLICATIONS/*EPIDEMIOLOGY/*TRANSMISSION  Male  Risk Factors
       Sarcoma, Kaposi's/*EPIDEMIOLOGY/ETIOLOGY  Sex Behavior  Sexual Partners
       Support, Non-U.S. Gov't  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).